AXLR8.COM LIMITED

Company number 02828911 ·

Active

Net assets, total assets & total liabilities 2017 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£150k -£100k -£50k £0 £50k £100k £150k £200k £250k 2017 2018 2019 2020 2021 2022 2023 2024 2025 2025 Total assets 2017: £193,726 Total assets 2018: £174,949 Total assets 2019: £203,383 Total assets 2020: £170,222 Total assets 2021: £193,900 Total assets 2022: £176,601 Total assets 2023: £143,733 Total assets 2024: £190,629 Total assets 2025: £131,464 Total assets 2025: £101,477 Total assets Net assets 2020: £60,928 Net assets 2021: £82,879 Net assets 2022: £64,516 Net assets 2023: £26,293 Net assets 2024: £69,215 Net assets 2025: £33,618 Net assets 2025: £4,616 Net assets Total liabilities 2017: -£147,666 Total liabilities 2018: -£144,324 Total liabilities 2019: -£121,397 Total liabilities 2020: -£75,893 Total liabilities 2021: -£77,661 Total liabilities 2022: -£78,272 Total liabilities 2023: -£78,362 Total liabilities 2024: -£82,336 Total liabilities 2025: -£67,184 Total liabilities 2025: -£61,796 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2025 – 2025

0 1 2 3 4 5 2025 2025 2025: 5 2025: 5

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 13 years

Latest accounts (2025-12-31): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-12-31 £101,477 -£61,796 £4,616 5
2025-03-31 £131,464 -£67,184 £33,618 5
2024-03-31 £190,629 -£82,336 £69,215
2023-03-31 £143,733 -£78,362 £26,293
2022-03-31 £176,601 -£78,272 £64,516
2021-03-31 £193,900 -£77,661 £82,879
2020-03-31 £170,222 -£75,893 £60,928
2019-03-31 £203,383 -£121,397
2018-03-31 £174,949 -£144,324
2017-03-31 £193,726 -£147,666
2016-03-31 £178,558 -£135,363
2015-03-31 £154,211 -£100,496 £57,706
2014-03-31 £116,423 -£89,613 £38,080

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.